These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3904441)

  • 1. Pharmacokinetic overview of indomethacin and sustained-release indomethacin.
    Yeh KC
    Am J Med; 1985 Oct; 79(4C):3-12. PubMed ID: 3904441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of new indomethacin dosage forms.
    Waller ES
    Pharmacotherapy; 1983; 3(6):324-33. PubMed ID: 6361702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indomethacin serum concentrations in man. Effects of dosage, food, and antacid.
    Emori HW; Paulus H; Bluestone R; Champion GD; Pearson C
    Ann Rheum Dis; 1976 Aug; 35(4):333-8. PubMed ID: 970990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of sustained release on the pharmacokinetic profile of indomethacin in man.
    Yeh KC; Berger ET; Breault GO; Lei BW; McMahon FG
    Biopharm Drug Dispos; 1982; 3(3):219-30. PubMed ID: 7139063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of food and repeated dosing on the bioavailability of indomethacin from a multiple-units controlled-release formulation.
    Skinhøj A; Bechgaard H; Chasseaud LF; Brodie RR; Sharman JM; Taylor T; Hunter JO
    Int J Clin Pharmacol Ther Toxicol; 1984 Oct; 22(10):557-61. PubMed ID: 6511132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biopharmaceutical evaluation of 'Osmosin'.
    Rogers JD
    Curr Med Res Opin; 1983; 8 Suppl 2():38-54. PubMed ID: 6851625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of concomitant aspirin administration on the pharmacokinetics of indomethacin in man.
    Kwan KC; Breault GO; Davis RL; Lei BW; Czerwinski AW; Besselaar GH; Duggan DE
    J Pharmacokinet Biopharm; 1978 Dec; 6(6):451-76. PubMed ID: 731412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of indomethacin.
    Alván G; Orme M; Bertilsson L; Ekstrand R; Palmér L
    Clin Pharmacol Ther; 1975 Sep; 18(3):364-73. PubMed ID: 1100305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indomethacin sustained-release?
    Green JA
    Drug Intell Clin Pharm; 1984 Dec; 18(12):1004-7. PubMed ID: 6391883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of a sustained-release product of indomethacin in the elderly.
    Bruguerolle B; Barbeau G; Bélanger PM; Labrecque G
    Gerontology; 1986; 32(5):277-85. PubMed ID: 3569930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of an osmotically controlled delivery indomethacin preparation in normal volunteers.
    Bertouch JV; Maycock S; Harrington B; Brooks PM
    Clin Exp Pharmacol Physiol; 1983; 10(4):411-4. PubMed ID: 6627754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo evaluation of single-unit commercial immediate-and sustained-release capsules compared with multiple-unit polystyrene microparticles dosage forms of indomethacin.
    Tamilvanan S; Sa B
    PDA J Pharm Sci Technol; 2008; 62(3):177-90. PubMed ID: 18661867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of indomethacin from a modified release system containing indomethacin as the lysine salt.
    Marzo A; Reiner A; Arrigoni Martelli E; Conte U; Colombo P; La Manna A
    Eur J Clin Pharmacol; 1987; 32(1):85-7. PubMed ID: 3108010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronopharmacokinetic study of a prolonged release form of indomethacin.
    Guissou P; Cuisinaud G; Llorca G; Lejeune E; Sassard J
    Eur J Clin Pharmacol; 1983; 24(5):667-70. PubMed ID: 6873148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steady-state pharmacokinetics of a novel extended-release metformin formulation.
    Timmins P; Donahue S; Meeker J; Marathe P
    Clin Pharmacokinet; 2005; 44(7):721-9. PubMed ID: 15966755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative multiple dose kinetics of two formulations of indomethacin.
    Verbesselt R; Tjandramaga TB; Mullie A; De Schepper PJ; Cook T; Derouwaux C; Kramp R; Hwang S
    Eur J Clin Pharmacol; 1983; 24(4):563-8. PubMed ID: 6861873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Pharmacokinetics of indomethacin.
    Helleberg L
    Clin Pharmacokinet; 1981; 6(4):245-58. PubMed ID: 7249487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of osmotically controlled indomethacin delivery systems after repeated dosing.
    Bayne W; Place V; Theeuwes F; Rogers JD; Lee RB; Davies RO; Kwan KC
    Clin Pharmacol Ther; 1982 Aug; 32(2):270-6. PubMed ID: 7094513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of sustained-release etodolac.
    Benet LZ
    Rheumatol Int; 1993; 13(2 Suppl):S3-5. PubMed ID: 8210922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple-dose pharmacokinetics of diazepam following once-daily administration of a controlled-release capsule.
    Wills RJ; Colburn WA
    Ther Drug Monit; 1983; 5(4):423-6. PubMed ID: 6419420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.